| What is Nanomedicine? Postgraduate Medical Centre, Leeds, 13 February 2009 |
Programme |
 |
09.30 – 10.00 Registration and Coffee
10.00 – 10.10 Introductions
10.10 – 10.20 Aims of the course
Professor Shervanthi Homer-Vanniasinkam, Consultant Vascular Surgeon, Leeds Vascular Institute; Clinical Sub-Dean, Leeds University Medical School; Professor of Translational Vascular Medicine, University of Bradford
10.20 – 10.50 Nanotechnology in Context
the new medical technologies the emergence of nanomedicine what exactly does “nano” mean? some useful “nano” definitions main sub-disciplines of nanomedicine Richard Moore, Manager - Nanomedicine and Lifesciences, Institute of Nanotechnology
10.50 – 11.30 Nanomedicine – Clinical Perspectives and Needs
Professor Shervanthi Homer-Vanniasinkam
11.30 – 12.10 Nanotechnology and Nanomanufacturing at Leeds
potential targeted drug delivery, medical device and regenerative medicine applications commercialisation and business aspects Professor Terry Wilkins, NanoManufacturing Institute (Nmi), University of Leeds
12.10 – 12.45 Lunch
12.50 – 13.30 Nanotechnology in the fields of:
in vitro diagnostics biosensors in vivo diagnostics Professor Seamus Higson, Cranfield University
13.30 – 14.10 Nanotechnology in the fields of:
imaging gene and cell therapy regenerative medicine Dr Ravi Vohra, Endothelial Cell Biology Unit, Leeds Institute for Genetics, Health and Therapeutics (LIGHT)
14.10 – 14.50 Nanotechnology in the fields of:
infection control “smart” and functionalised materials Richard Moore, Institute of Nanotechnology
14.50 – 15.10 Refreshments
15.10 – 15.50 Risk Management, Regulation, Reimbursement and Other Challenges
Richard Moore, Nanomedicine and Lifesciences, Institute of Nanotechnology
15.50 – 16.50 Group Discussion – Moving Nanomedicine Forwards to the Patient
16.50 – 17.00 Summing up and Closing Remarks
Professor Shervanthi Homer-Vanniasinkam
The courses are also delivered under the general umbrella of the NanoMedNet network (www.nano.org.uk/nanomednet) which is committed to:
- providing the most up-to-date information on all aspects of the emerging
field of nanomedicine.
- raising the awareness of, and developing the education and training
of, medical professionals and related medical and scientific disciplines
in all aspects of nanomedicine.
- contributing to medical nanotechnology transfer and the commercialisation
of novel ideas through the development of a clinician-researcher-industry
community.